Free Trial
NASDAQ:SHPH

Shuttle Pharmaceuticals (SHPH) Stock Price, News & Analysis

Shuttle Pharmaceuticals logo
$3.50 -0.15 (-4.11%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$3.53 +0.03 (+0.86%)
As of 08/1/2025 07:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Shuttle Pharmaceuticals Stock (NASDAQ:SHPH)

Key Stats

Today's Range
$3.33
$3.70
50-Day Range
$3.26
$5.59
52-Week Range
$3.00
$82.50
Volume
29,879 shs
Average Volume
168,865 shs
Market Capitalization
$1.54 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Shuttle Pharmaceuticals Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
16th Percentile Overall Score

SHPH MarketRank™: 

Shuttle Pharmaceuticals scored higher than 16% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Shuttle Pharmaceuticals.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Shuttle Pharmaceuticals is -0.84, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Shuttle Pharmaceuticals is -0.84, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Shuttle Pharmaceuticals has a P/B Ratio of 0.80. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Shuttle Pharmaceuticals' valuation and earnings.
  • Percentage of Shares Shorted

    4.03% of the float of Shuttle Pharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    Shuttle Pharmaceuticals has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Shuttle Pharmaceuticals has recently decreased by 12.47%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Shuttle Pharmaceuticals does not currently pay a dividend.

  • Dividend Growth

    Shuttle Pharmaceuticals does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.03% of the float of Shuttle Pharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    Shuttle Pharmaceuticals has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Shuttle Pharmaceuticals has recently decreased by 12.47%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Shuttle Pharmaceuticals has a news sentiment score of -1.08. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.45 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Shuttle Pharmaceuticals this week, compared to 1 article on an average week.
  • MarketBeat Follows

    Only 1 people have added Shuttle Pharmaceuticals to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Shuttle Pharmaceuticals insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    12.60% of the stock of Shuttle Pharmaceuticals is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 4.58% of the stock of Shuttle Pharmaceuticals is held by institutions.

  • Read more about Shuttle Pharmaceuticals' insider trading history.
Receive SHPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Shuttle Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SHPH Stock News Headlines

Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.
See More Headlines

SHPH Stock Analysis - Frequently Asked Questions

Shuttle Pharmaceuticals' stock was trading at $21.4750 at the start of the year. Since then, SHPH stock has decreased by 83.7% and is now trading at $3.50.

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) announced its earnings results on Thursday, May, 8th. The company reported ($7.50) earnings per share for the quarter.

Shuttle Pharmaceuticals shares reverse split before market open on Monday, June 16th 2025.The 1-25 reverse split was announced on Thursday, June 12th 2025. The number of shares owned by shareholders was adjusted after the market closes on Friday, June 13th 2025. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Shuttle Pharmaceuticals (SHPH) raised $10 million in an IPO on Wednesday, August 31st 2022. The company issued 1,225,888 shares at a price of $8.13 per share.

Shares of SHPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Shuttle Pharmaceuticals investors own include MSP Recovery (LIFW), NIO (NIO), Tesla (TSLA), Broadcom (AVGO), AMTD Digital (HKD) and NVIDIA (NVDA).

Company Calendar

Last Earnings
5/08/2025
Today
8/02/2025
Next Earnings (Estimated)
9/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:SHPH
CIK
1757499
Fax
N/A
Employees
5
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($4.15)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$9.15 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-1,203.10%
Return on Assets
-370.42%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.78
Quick Ratio
2.78

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.35 per share
Price / Book
0.80

Miscellaneous

Outstanding Shares
440,000
Free Float
384,000
Market Cap
$1.54 million
Optionable
Not Optionable
Beta
-1.08

Social Links

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:SHPH) was last updated on 8/3/2025 by MarketBeat.com Staff
From Our Partners